Drug intelligence / Profile preview

TPX-113

Development stage
Preclinical
Lead developer
Tego Science
Modality
Allogeneic CAR-T → CAR-T Cells → Engineered T Cells → Adoptive Cell Transfer → Cell Therapies, CAR-NK Cells → Other Engineered Cells → Adoptive Cell Transfer → Cell Therapies, Allogeneic iPSCs → iPSCs → Pluripotent Stem Cells → Stem Cell Therapies → Cell Therapies
Administration
Topical
01

Overview

TPX-113 is an allogeneic cell therapy consisting of cultured mucosal cells, currently under development by Tego Science. It is designed for the treatment of oral mucosal defects, aiming to facilitate the repair and regeneration of damaged oral tissues. As an allogeneic product, TPX-113 utilizes cells derived from a donor rather than the patient, which allows for standardized manufacturing and potential "off-the-shelf" clinical availability. This distinguishes it from autologous therapies, such as TPX-112, which require patient-specific cell harvesting. TPX-113 is currently in the preclinical stage of development.

Beyond the preview

Go deeper on TPX-113.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TPX-113.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call